SONM — Stock Film
STOCK FILMSCENE 1/11SONM · $3.00
Stock Expert AI presents
SONM
DNA X, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
DNA X, Inc. A quick introduction.

On the stock market since 2019, it operates in the world of technology. It has 4 employees. Now — the numbers.

on the stock market since 2019
4 employees
$3.1M market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

WHERE DOES THE MONEY COME FROM?
52%Smartphones
Smartphones 52%Feature Phones 40%Connected Solutions 7%Accessories and Other 1%
52% of all revenue comes from a single line: Smartphones.

The biggest line carries real weight, but it doesn’t decide everything on its own.

In the vault right now:
$0
DEBT: $5.1M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
33
very weak

Clearly below the class average.

FINANCIAL STRENGTH
23
very weak

Clearly below the class average.

VALUATION
0
very weak

Clearly below the class average.

GROWTH
15
very weak

Clearly below the class average.

PRICE MOMENTUM
16
very weak

Clearly below the class average.

WORTH WATCHING

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled2/10
Thin profit on each sale3/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

THE BRIGHT SIDE

Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $20.7M against $0 in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, SONM sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: SONM is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 24, 2026 · stockexpertai.com · Stock Film